Skip to main content
OpenTrials
Completed

NCT Number: NCT05936892

Comparative Effects of UE Aerobic and Resistance Training on Cardiorespiratory Fitness in Hypertensive Patients

simple random sampling into group A & group B to collect data. Group A will be given upper extremity aerobic training and group B will be given upper extremity resistance training. The study will be completed within the time duration of ten months. Primary Outcome measures of the research will be pain, range of motion, and quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Blood Pressure

Age range

35 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Multan Institute of Cardiology, Multan

Multan Khurd, Punjab Province, Pakistan

About this study

A randomized clinical trial will be conducted at Multan institute of cardiology, Multan. Non probability convenient sampling technique will be applied on--patients who will be allocated through simple random sampling into group A & group B to collect data. Group A will be given upper extremity aerobic training and group B will be given upper extremity resistance training. The study will be completed within the time duration of ten months. Primary Outcome measures of the research will be pain, range of motion, and quality of life. Data will be analyzed using SPSS software version 25. After assessing normality of data by Shapiro-wilk test, it will be decided either parametric or non-parametric test will be used within a group or between two groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age group of 35-65years
  • Both male and females
  • Patients with blood pressure >140/90mm Hg

Exclusion criteria

  • Regular engagement in physical exercise training in past 4 weeks
  • Patients with secondary hypertension
  • Patients using more than one hypertensive drugs
  • Recent myocardial infarction
  • Congestive heart failure
  • Uncontrolled cardiac arrythmia

Treatment and study plan

upper extremity aerobic training

Other

upper extremity aerobic training & baseline treatment will be given. Overall session time will be 40-45 minutes

upper extremity resistance training

Other

upper extremity resistance training Overall session time will be 40-45 minutes

Primary outcomes

  1. 6 MWT RESISTANCE TRAINING ON CARDIORESPIRATORY FITNESS IN HYPERTENSIVE PATIENTS

    Time frame: 4 weeks

    The 6MWT is a practical simple test that requires a 100-ft hallway but no exercise equipment or advanced training for technicians. This test measures the distance that a patient can quickly walk on a flat, hard surface in a period of 6 minutes (the 6MWD).The self-paced 6MWT assesses the submaximal level of functional capacity. (19) According to studies, the distance walked by a healthy subject on six-minute walk test ranges from 400 to 700m.

    • Men ranged from 735m to 580m.
    • Women ranged from 657m to 500m.

Secondary outcomes

  1. Borg rating of perceived exertion (RPE)

    Time frame: 4 weeks

    Borg rating of perceived exertion (RPE) is an outcome measure scale used in knowing exercise intensity prescription. It is used in monitoring progress and mode of exercise in cardiac patients as well as in other patient populations undergoing rehabilitation and endurance training.Borg RPE scale was developed by Gunnar Borg for rating exertion and breathlessness during physical activity ; that is, how hard the activity is as shown by high heart and respiration rate , profuse perspiration and muscle exertion.

    RPE scale contains 10 points (20).

    • 1 denotes very light activity
    • 2-3 denotes light activity
    • 4-6 denotes moderate activity
    • 7-8 denotes vigorous activity
    • 9 denotes very hard activity
    • 10 denotes maximum effort activity training.

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jul 10, 2023
Registry last updated
Jun 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.